(19)
(11) EP 4 823 585 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24828786.4

(22) Date of filing: 13.12.2024
(51) International Patent Classification (IPC): 
A61K 31/7088(2006.01)
C12N 15/113(2010.01)
A61K 31/713(2006.01)
C12Q 1/6883(2018.01)
(52) Cooperative Patent Classification (CPC):
C12N 2310/11; C12Q 1/6883; A61K 31/713; C12N 15/1137; C12N 2310/341; C12N 2310/3231; C12N 2310/315
(86) International application number:
PCT/EP2024/086162
(87) International publication number:
WO 2025/125542 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 15.12.2023 EP 23217073

(71) Applicant: F. Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventors:
  • DAETWYLER, Philipp
    4070 Basel (CH)
  • SCHWAB, Dietmar
    4070 Basel (CH)

(74) Representative: Rodriguez Novoa, Lorena 
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel
4070 Basel (CH)

   


(54) INTRATHECAL DOSAGE METHOD